icrf 193 has been researched along with camptothecin in 7 studies
Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (camptothecin) | Trials (camptothecin) | Recent Studies (post-2010) (camptothecin) |
---|---|---|---|---|---|
155 | 0 | 30 | 13,002 | 2,229 | 5,391 |
Protein | Taxonomy | icrf 193 (IC50) | camptothecin (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.05 | |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.4 | |
DNA topoisomerase 1 | Homo sapiens (human) | 1.9799 | |
Somatostatin receptor type 1 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 2 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 4 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 3 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 5 | Homo sapiens (human) | 0.0022 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.97 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.05 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andoh, T; Ishida, R; Ishimi, Y | 1 |
Furue, H | 1 |
Andoh, T; Aratani, Y; Koyama, H | 1 |
Beere, HM; Chresta, CM; Hickman, JA | 1 |
Ishida, R; Nishida, K; Seto, M | 1 |
Ayusawa, D; Endoh, M; Fuji, M; Hossain, MN; Miki, K | 1 |
Takeda, S; Takenaka, K; Wang, X | 1 |
1 review(s) available for icrf 193 and camptothecin
Article | Year |
---|---|
[Topoisomerase inhibitors developing in Japan].
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzopyrans; Camptothecin; Diketopiperazines; Glycosides; Humans; Irinotecan; Neoplasms; Phenazines; Piperazines; Razoxane; Topotecan | 1993 |
6 other study(ies) available for icrf 193 and camptothecin
Article | Year |
---|---|
Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.
Topics: Camptothecin; Cell Line; Chromosomes; Diketopiperazines; DNA Replication; DNA, Viral; Electrophoresis, Gel, Two-Dimensional; Etoposide; HeLa Cells; Humans; Neutralization Tests; Piperazines; Simian virus 40; Topoisomerase II Inhibitors | 1992 |
Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Topics: Adenine Phosphoribosyltransferase; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; CHO Cells; Chromosome Aberrations; Cricetinae; Diketopiperazines; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Mutagenesis; Mutagenicity Tests; Nucleic Acid Heteroduplexes; Piperazines; Recombination, Genetic; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transfection | 1996 |
Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Diketopiperazines; DNA Damage; Enzyme Inhibitors; Etoposide; Formamides; HL-60 Cells; Humans; Piperazines; Topoisomerase II Inhibitors | 1996 |
Different susceptibilities of postmitotic checkpoint-proficient and -deficient Balb / 3T3 cells to ICRF-193, a catalytic inhibitor of DNA topoisomerase II.
Topics: 3T3 Cells; Animals; Camptothecin; Cell Survival; Chromosome Segregation; Diketopiperazines; DNA; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Irinotecan; Mice; Mitosis; Piperazines; S Phase; Topoisomerase II Inhibitors | 2001 |
Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses.
Topics: Antimetabolites; Antineoplastic Agents; Bromodeoxyuridine; Camptothecin; Diketopiperazines; Enzyme Inhibitors; Gene Expression Regulation; HeLa Cells; Herbicides; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Hydrogen Peroxide; Oxidants; Paraquat; Piperazines; RNA, Small Interfering | 2007 |
PTIP promotes DNA double-strand break repair through homologous recombination.
Topics: Animals; B-Lymphocytes; Camptothecin; Carrier Proteins; Chickens; Diketopiperazines; DNA Breaks, Double-Stranded; DNA Repair; DNA-Binding Proteins; Gene Knockdown Techniques; Genomic Instability; HeLa Cells; Homologous Recombination; Humans; Molecular Sequence Data; Nuclear Proteins; Piperazines; Topoisomerase Inhibitors | 2010 |